The Asia-Pacific Bioinformatics Market is witnessing significant growth due to the region's increasing focus on genomics, proteomics, and drug discovery. The rising prevalence of chronic diseases and the expanding biopharmaceutical industry are driving demand for precision medicine and biomarker identification. The adoption of next-generation sequencing technologies has generated vast genomic data, necessitating bioinformatics solutions for efficient data analysis and interpretation. Additionally, the region's growing awareness of personalized medicine and collaborations between academia and industry contribute to the market's expansion, fostering advancements in healthcare and research.
Access Full Report @ https://www.databridgemarketresearch.com/ar/reports/asia-pacific-apac-bioinformatics-market
Data Bridge Market Research analyses that the Asia-Pacific bioinformatics market is expected to reach a value of CAGR of around 17.8% during the forecast period from 2022-2029. The rapid progress in genomics and proteomics research has generated vast amounts of biological data. Bioinformatics plays a crucial role in managing, analyzing, and interpreting this big data to extract meaningful insights, leading to the development of personalized medicine, targeted therapies, and precision diagnostics.
Key Findings of the Study
The adoption of next-generation sequencing is expected to drive the market's growth rate
The widespread adoption of next-generation sequencing (NGS) technologies in the Asia-Pacific region has revolutionized genomic research, producing a massive influx of genomic data. To manage and extract meaningful insights from this vast data, bioinformatics solutions have become essential. These tools facilitate efficient data analysis, interpretation, and visualization, enabling researchers to study genetic variations, identify disease-related mutations, and understand the genetic basis of various conditions. NGS and bioinformatics synergy empower advancements in genomics, personalized medicine, and agricultural biotechnology.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Knowledge Management Tools, Bioinformatics Software and Services), Sector (Medical Biotechnology, Academics, Animal Biotechnology, Agricultural Biotechnology, Environmental Biotechnology, Forensic Biotechnology and Others), Application (Genomics and Drug Development, Proteomics, Evolutionary Studies, Agricultural Studies, Veterinary Science, Metabolomics, Transcriptomics and Others), Purchase Mode (Group Purchase and Individual Purchase), Method (Genomics and Proteomics) End-User, (Research and Academic Institutes, Clinical Research Organization, Biotech and Pharmaceutical Companies, Research Laboratories, Hospital and Others)
|
|
Countries Covered
|
China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific
|
|
Market Players Covered
|
Thermo Fisher Scientific Inc. (U.S.), Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), QIAGEN (Germany), SOPHiA GENETICS (Switzerland), BGI (China),Eurofins Scientific (Luxembourg), Waters Corporation (U.S.), Partek Incorporated (U.S.), Dassault Système (France), Bayer AG (Germany), PerkinElmer Inc. (U.S.), Quest Diagnostics Incorporated (U.S.), AstridBio Technologies Inc. (Canada), BioBam (Spain), Strand Life Science (India), GenoFAB, Inc. (U.S.)
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The Asia-Pacific bioinformatics market is segmented on the basis of type, sector, application, purchase mode, genomics, and end user
- On the basis of type, the Asia-Pacific bioinformatics market is segmented into knowledge management tools, bioinformatics software, and services.
- On the basis of sector, the Asia-Pacific bioinformatics market is segmented into medical biotechnology, academics, animal biotechnology, agricultural biotechnology, environmental biotechnology, forensic biotechnology, and others.
- On the basis of application, the Asia-Pacific bioinformatics market is segmented into genomics and drug development, proteomics, evolutionary studies, agricultural studies, veterinary science, metabolomics, transcriptomics, and others.
- On the basis of purchase mode, the Asia-Pacific bioinformatics market is segmented into group purchases and individual purchases.
- On the basis of method, the Asia-Pacific bioinformatics market is segmented into genomics and proteomics.
- On the basis of end-user, the Asia-Pacific bioinformatics market is segmented into research and academic institutes, clinical research organizations, biotech and pharmaceutical companies, research laboratories, hospitals, and others.
Major Players
Data Bridge Market Research recognizes the following companies as the major Asia-Pacific Bioinformatics market players in Asia-Pacific Bioinformatics market are Illumina, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), QIAGEN (Germany), SOPHiA GENETICS (Switzerland), BGI (China),Eurofins Scientific (Luxembourg), Waters Corporation (U.S.), Partek Incorporated (U.S.)
Market Developments
- In 2022, Thermo Fisher Scientific Inc launched the CE-IVD Marked Next-Generation Sequencing (NGS) Instrument for Use in Clinical Labs. The CE-IVD Marked Next-Generation Sequencing Instrument is used to perform diagnostic testing and clinical research on a single instrument.
- In 2022, Illumina, Inc. and AstraZeneca formed a strategic research collaboration to expedite the discovery of therapeutic targets by combining their strengths in AI-based genome interpretation and genomic analysis tools with industry knowledge.
- In 2022, Thermo Fisher Scientific joined the Pennsylvania Biotechnology Center (PABC) as a founding sponsor of both the Philadelphia-based B+Labs incubator and the PABC site in Doylestown, Pennsylvania, where emerging life science enterprises can accelerate their progress to commercialization.
- In 2021, BGI and the Ministry of Health of Brunei expanded their partnership to carry out extensive cooperation in public health emergency response and public health testing screening and diagnostic services, including reproductive health, personalized drug guidance, early cancer screening, and detection of unknown pathogens.
- In 2020, Charles River Laboratories, Inc. entered into a partnership with Fios Genomics to gain access to the expertise of Fios Genomics in the field of bioinformatics, statistics, and biology.
Regional Analysis
Geographically, the countries covered in the Asia-Pacific bioinformatics market report are China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific
As per Data Bridge Market Research analysis:
China is the dominant region in the Asia-Pacific bioinformatics market during the forecast period 2022-2029
China's expected dominance in the Asia-Pacific bioinformatics market is attributed to several factors. The country has witnessed a significant increase in research and development activities, fostering demand for integrated bioinformatics solutions in proteomic, genomic, and clinical diagnostics. Additionally, the growing need for advanced computational tools in biological research further propels the adoption of bioinformatics. China's focus on advancing healthcare, agricultural research, and biotechnology sectors also contributes to the increasing demand for bioinformatics tools and services in the region.
For more detailed information about the Asia-Pacific bioinformatics market report, click here – https://www.databridgemarketresearch.com/ar/reports/asia-pacific-apac-bioinformatics-market
